Global Pharmaceutical Contract Manufacturing Market to reach USD 165.57 billion by 2027.Global Pharmaceutical Contract Manufacturing Market is valued approximately USD 99.8 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period 2021-2027. Pharmaceutical contract manufacturing is the process of outsourcing of the drug development, API manufacturing or biologic manufacturing by pharmaceutical companies to the vendors. This is done for the continued supply of the quality products to the customers in a cost-effective way, expansion of production capabilities and increased focus on overall productivity and efficiency of the business, ultimately improving the revenues of the business. The exponential growth of the pharmaceutical industry in the past few years, growing demand of drugs and biologics and increasing investment in research and developments of drugs are propelling the market growth of Pharmaceutical Contract Manufacturing Market. According to Statista, the total global pharmaceutical market was pegged at about 1.27 trillion USD in 2020 as compared to 390 billion dollars in 2001. It also states that research and development spending in the pharmaceutical industry totaled 186 billion USD globally in 2019, a significant increase from 136 billion USD in 2012. In 2019, the United States was the largest pharmaceutical market, generating more than 490 billion USD in revenue. Europe, at the same time, generated 195 billion USD. The issue related to the serialization of drugs at every stage of supply chain may act as a restraint for its growth. However, increasing expiration of patents of many drugs has paved the way for production of generics. This acts as an opportunity for Pharmaceutical Contract Manufacturing Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of Pharmaceutical Contract Manufacturing Market. Due to presence of largest pharmaceutical players as well as higher per capita income, North America emerged as a significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit highest growth rate for the forecast period 2021-2027 owing to the growing production and demand for drugs and biologics. Rising disposable income and growing efforts of the government to make the region hub for pharmaceuticals will also boost the market growth in this region.

Major market player included in this report are:
Boehringer Ingelheim GmbH
Lonza
Grifols S.A
Jubilant Life Sciences Limited
Pfizer, Inc. (Pfizer CenterOne)
Charles River Laboratories International, Inc.
Albany Molecular Research, Inc.
Covance, Inc. (LabCorp)
QuintilesIMS
Baxter BioPharma Solutions

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Services:
Pharmaceutical Manufacturing Services
Drug Development Services
Biologics Manufacturing Services
By End-Users:
Big Pharmaceutical Companies
Small & Medium-Sized Pharmaceutical Companies
Generic Pharmaceutical Companies
Other End Users

By Region:
North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global Pharmaceutical Contract Manufacturing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors